Human flavin monoxygenase 1 (FMO1) as a catalyst of nicotine N-Oxidation

被引:0
|
作者
Murphy, Sharon E. [1 ]
von Weymarn, Linda B. [1 ]
Hinrichs, Anthony L. [2 ]
机构
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[2] Washington Univ, Dept Psychiat, St Louis, MO USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
309
引用
收藏
页码:152 / 153
页数:2
相关论文
共 50 条
  • [31] Identification of amino acid residues associated with modulation of flavin-containing monooxygenase (FMO) activity by imipramine: Structure/function studies with FMO1 from pig and rabbit
    Wyatt, MK
    Overby, LH
    Lawton, MP
    Philpot, RM
    BIOCHEMISTRY, 1998, 37 (17) : 5930 - 5938
  • [32] Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity
    Störmer, E
    Roots, I
    Brockmöller, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (06) : 553 - +
  • [33] THE FLAVIN-CONTAINING MONOOXYGENASES IN RAT-LIVER - EVIDENCE FOR THE EXPRESSION OF A 2ND FORM DIFFERENT FROM FMO1
    MORONI, P
    LONGINSAUVAGEON, C
    BENOIT, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 212 (03) : 820 - 826
  • [34] Nicotine-N′-Oxidation by Flavin Monooxygenase Enzymes
    Perez-Paramo, Yadira X.
    Chen, Gang
    Ashmore, Joseph H.
    Watson, Christy J. W.
    Nasrin, Shamema
    Adams-Haduch, Jennifer
    Wang, Renwei
    Gao, Yu-Tang
    Koh, Woon-Puay
    Yuan, Jian-Min
    Lazarus, Philip
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (02) : 311 - 320
  • [35] PULMONARY N-OXIDATION OF NICOTINE AND PYRIDINE IN SEVERAL ANIMAL SPECIES
    OHMIYA, Y
    FUJISAWA, S
    NAKAI, K
    FOLIA PHARMACOLOGICA JAPONICA, 1984, 83 (06) : P59 - P60
  • [36] Bioelectrochemical platform with human monooxygenases: FMO1 and CYP3A4 tandem reactions with phorate
    Cheropkina, Hanna
    Catucci, Gianluca
    Cesano, Federico
    Marucco, Arianna
    Gilardi, Gianfranco
    Sadeghi, Sheila J.
    BIOELECTROCHEMISTRY, 2023, 150
  • [37] Correlation between phenotypes of FMO obtained by ranitidine N-oxidation and genotypes of FMO3 in a Korean population.
    Cha, YN
    Lee, KH
    Chung, WG
    Park, CS
    Kang, JH
    Baek, HM
    Kang, JS
    Roh, HK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 183 - 183
  • [38] Nicotinamide N-Oxidation by CYP2E1 in Human Liver Microsomes
    Real, Alexander Michael
    Hong, Shangyu
    Pissios, Pavlos
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (03) : 550 - 553
  • [39] THE ROLE OF FLAVIN-CONTAINING MONOOXYGENASE IN THE N-OXIDATION OF THE PYRROLIZIDINE ALKALOID SENECIONINE
    WILLIAMS, DE
    REED, RL
    KEDZIERSKI, B
    ZIEGLER, DM
    BUHLER, DR
    DRUG METABOLISM AND DISPOSITION, 1989, 17 (04) : 380 - 386
  • [40] Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin
    Parte, P
    Kupfer, D
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (10) : 1446 - 1452